Unknown

Dataset Information

Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis.


ABSTRACT:

Background

Lung cancer (LC) is a common malignant tumor with a high incidence and poor prognosis. Early LC could be cured, but the 5-year-survival rate for patients advanced is extremely low. Early screening of tumor biomarkers through plasma could allow more LC to be detected at an early stage, leading to a earlier treatment and a better prognosis.

Methods

This study was based on total proteomic analysis and parallel reaction monitoring validation of peripheral blood from 20 lung adenocarcinoma patients and 20 healthy individuals. Furthermore, differentially expressed proteins closely related to prognosis were analysed using Kaplan-Meier Plotter and receiver operating characteristic curve (ROC) curve analysis.

Results

The candidate proteins GAPDH and RAC1 showed the

SUBMITTER: Chen H 

PROVIDER: S-EPMC9677906 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature